After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
The buzz of Allu Arjun starrer film 'Pushpa: The Rule' (Pushpa 2) has been made. E
An unidentified person called the Mumbai traffic police control room threatening to carry out 26/
On March 3, Agriculture Minister Gurmeet Singh Khuddian will resume the broken talks between Chie
Is this agreement between China and Bhutan a tension for India?
On Thursday 14 October, the foreign ministers of China and Bhutan held a meeting via video confer
Delhi Capitals spinner Akshar Patel believes that the introduction of the Impact Player rule in t
Amid growing tension in the world, the US Navy has raised the concern of western countries by say
Pakistan, which has reached the brink of starvation, is not desisting from its antics. He has all
Railways Jobs Case: CBI and ED raid in Bihar-Jharkhand, raids on RJD leaders' bases
The Central Investigation Agency is conducting raids in Bihar and Jharkhand on Wednesday morning.
The Elephnat Whisphers : 'The Elephant Whispers' won the Oscar Award, you can watch this film here
Oscar Awards 2023: The audience was eagerly waiting for the Oscar Awards 2023. This time this Osc
Currently, there are nine contestants remaining on Bigg Boss 19. The reality show's finale will b
